Guizhou Redstar Developing (600367.SH) subsidiary Dazhu Hongdie to cease production, with future operations to be taken over by Redsta.
Hongxing Development (600367.SH) announced that its controlling subsidiary, Chongqing Dazu Hongdie Strontium Co., Ltd. (referred to as Dazu Hongdie), needs to relocate to a chemical park in accordance with the "Guiding Opinions of the General Office of the State Council on Promoting the Relocation and Transformation of Hazardous Chemical Production Enterprises in Urban Population Intensive Areas" (State Council Document [2017] No. 77).
The relocation and expansion project of Chongqing Rui Desi Optical Technology Co., Ltd. (referred to as Rui Desi), in which the shareholders of Rui Desi and Dazu Hongdie are the same and the shareholding proportions are consistent, has been basically completed and is ready for trial production. The company plans to stop production at Dazu Hongdie, and after the shutdown, some production equipment will be transferred to the company's controlling subsidiary Rui Desi, which will take over the subsequent business of Dazu Hongdie.
Guizhou Redstar Developing (600367.SH) announced that its controlling subsidiary, Chongqing Dazu Hongdie Strontium Industry Co., Ltd. (referred to as Dazu Hongdie), needs to relocate to a chemical industrial park according to the "Guiding Opinions of the General Office of the State Council on Promoting the Relocation and Transformation of Dangerous Chemical Production Enterprises in Urban Population-intensive Areas" (Guo Ban Fa [2017] No. 77).
The relocation and expansion project of Chongqing Ruidesda Optoelectronic Technology Co., Ltd. (referred to as Ruidesda) has been basically completed and has the conditions for trial production. The company plans to suspend production at Dazu Hongdie, and after the suspension, some production equipment will be transferred to its controlling subsidiary Ruidesda, where the subsequent business of Dazu Hongdie will be taken over.
Related Articles

Morgan Stanley: Consumer willingness to travel remains resilient, North American aviation industry "attractive"

CSRC approves Hongming Electronics' registration for the ChiNext IPO.

Jiangsu Lianhuan Pharmaceutical (600513.SH) subsidiary obtains registration certificate for the drug Amlopidine Besilate tablets.
Morgan Stanley: Consumer willingness to travel remains resilient, North American aviation industry "attractive"

CSRC approves Hongming Electronics' registration for the ChiNext IPO.

Jiangsu Lianhuan Pharmaceutical (600513.SH) subsidiary obtains registration certificate for the drug Amlopidine Besilate tablets.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


